Skip to content
10-Q

Quarterly Report

MEDINOTEC, INC. MDNC

0001663577-25-000018

← back to feed
Filed
Jan 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Jan 13, 2025 11.73M sh
Current Liabilities Q3 2025 · Nov 30, 2024 $1.47M
Current Liabilities Q3 2025 · Feb 29, 2024 $827.45K
Total Liabilities Q3 2025 · Nov 30, 2024 $2.54M
Total Liabilities Q3 2025 · Feb 29, 2024 $2.64M
Current Assets Q3 2025 · Nov 30, 2024 $4.92M
Current Assets Q3 2025 · Feb 29, 2024 $4.38M
Total Assets Q3 2025 · Nov 30, 2024 $5.36M
Total Assets Q3 2025 · Feb 29, 2024 $4.8M
Capex restated Q3 2025 · Nov 30, 2023 −$851
Operating Cash Flow Q3 2025 · Nov 30, 2023 $101.23K
Cash And Equivalents Q3 2025 · Nov 30, 2023 $2.68M
Cash And Equivalents Q3 2025 · Feb 28, 2023 $2.83M
Stockholders Equity Q3 2025 · Nov 30, 2023 $2.08M
Stockholders Equity Q3 2025 · Aug 31, 2023 $2.57M
Stockholders Equity Q3 2025 · Feb 28, 2023 $2.56M
Eps Basic Q3 2025 · Nov 30, 2023 −$0.04
Eps Basic Q3 2025 · Nov 30, 2023 −$0.04
Sga Expense Q3 2025 · Nov 30, 2023 $552.34K
Sga Expense Q3 2025 · Nov 30, 2023 $951.79K
Rd Expense Q3 2025 · Nov 30, 2023 $2.73K
Rd Expense Q3 2025 · Nov 30, 2023 $16.85K
Net Income Q3 2025 · Nov 30, 2023 −$492.37K
Net Income Q3 2025 · Nov 30, 2023 −$503.25K
Operating Income Q3 2025 · Nov 30, 2023 $257.91K
Operating Income Q3 2025 · Nov 30, 2023 $354.5K
Gross Profit Q3 2025 · Nov 30, 2023 $863.92K
Gross Profit Q3 2025 · Nov 30, 2023 $1.47M
Cost Of Revenue Q3 2025 · Nov 30, 2023 $1.14M
Cost Of Revenue Q3 2025 · Nov 30, 2023 $1.3M
Revenue Q3 2025 · Nov 30, 2023 $2M
Revenue Q3 2025 · Nov 30, 2023 $2.77M